Education
About Us
Working with TipRanks
Follow Us
Microbot Medical Inc (MBOT)
NASDAQ:MBOT
MBOT Stock Chart & Stats
$2.39
-$1.10(-38.87%)
At close: 4:00 PM EST
$2.39
-$1.10(-38.87%)
Day’s Range― - ―
52-Week Range$1.25 - $4.67
Previous CloseN/A
Volume6.51M
Average Volume (3M)2.49M
Market Cap
$160.51M
Enterprise Value$105.84M
Total Cash (Recent Filing)$80.16M
Total Debt (Recent Filing)$899.00K
Price to Earnings (P/E)―
Beta1.67
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.73
Shares Outstanding67,158,040
10 Day Avg. Volume2,397,724
30 Day Avg. Volume2,485,433
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)4.96
Price to Sales (P/S)0.00
P/FCF Ratio-1.98
Enterprise Value/Market Cap0.66
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-2.21K
Enterprise Value/Ebitda-7.88
Forecast
1Y Price Target
$7.50Price Target Upside213.81% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.35
Revenue Forecast (FY)$4.32M
Bulls Say, Bears Say
Bulls Say
Clinical And Hospital AdoptionAdoption by major hospitals like Emory University Hospital and Tampa General indicates early commercial traction that could encourage wider hospital interest in the robotic platform.
Regulatory And Product PositioningFDA clearance as the first single-use, remotely operated system for peripheral endovascular procedures provides a distinct regulatory and product advantage that supports market differentiation.
Reimbursement And Procedure ExpansionExisting reimbursement codes for complex peripheral vascular procedures and plans to deploy the system across multiple specialties could help drive clinical demand and revenue growth.
Bears Say
Commercialization RiskDelays in scaling the limited market release or in broader commercialization could slow revenue recognition and hinder expected growth.
Market Penetration And CompetitionSlower-than-expected uptake due to limited market size, low penetration rates, or competitive alternatives could reduce the system's achievable market share.
Profitability RiskContinued commercialization costs combined with uncertainty about expansion into cardio and neuro procedures could extend the path to profitability and pressure financial results.
Microbot Medical News
MBOT FAQ
What was Microbot Medical Inc’s price range in the past 12 months?
Microbot Medical Inc lowest stock price was $1.25 and its highest was $4.67 in the past 12 months.
What is Microbot Medical Inc’s market cap?
Microbot Medical Inc’s market cap is $160.51M.
When is Microbot Medical Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Microbot Medical Inc’s earnings last quarter?
Currently, no data Available
Is Microbot Medical Inc overvalued?
According to Wall Street analysts Microbot Medical Inc’s price is currently Undervalued.
Does Microbot Medical Inc pay dividends?
Microbot Medical Inc does not currently pay dividends.
What is Microbot Medical Inc’s EPS estimate?
Microbot Medical Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Microbot Medical Inc have?
Microbot Medical Inc has 67,158,040 shares outstanding.
What happened to Microbot Medical Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Microbot Medical Inc?
Currently, no hedge funds are holding shares in MBOT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Microbot Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$7.50 (213.81% Upside)
$7.50 (213.81% Upside)
Blogger Sentiment
Neutral
MBOT Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 16.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▲ 0.4%
Last 30 Days ▲ 2.1%
Last 30 Days ▲ 2.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
75.88%
12-Months-Change
Fundamentals
Return on Equity
-31.87%
Trailing 12-Months
Asset Growth
1469.89%
Trailing 12-Months
Company Description
Microbot Medical Inc
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
MBOT Stock 12 Month Forecast
Average Price Target
$7.50
▲(213.81% Upside)
Technical Analysis
Ownership Overview
―
Insiders
3.91% Mutual Funds
1.59% Other Institutional Investors
89.93% Public Companies and
Individual Investors